Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03093155
Title Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Yale University
Indications

ovary epithelial cancer

peritoneum cancer

fallopian tube cancer

Therapies

Bevacizumab + Ixabepilone

Ixabepilone

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Smilow Cancer Hospital at Yale New Haven New Haven Connecticut 06510 United States Details
Marlene & Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Baltimore Maryland 21201 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field